Takeda’s Global CSR Program, its flagship CSR activity, makes multi-year commitments in partnership with key global stakeholders. The Program is rooted in the company’s patient-centricity and dedication to disease prevention and the improvement of access to healthcare that transforms people’s lives in developing and emerging countries. Since its launch in 2016, Global CSR Program partnerships have been delivering tangible results, contributing significantly to global efforts to achieve the Sustainable Development Goals (SDGs).* Results range from expanding patient’s access to quality diagnosis and treatment, including immunization, in disease-endemic countries to training health workers and strengthening health systems worldwide.

“We look forward to helping change more lives for the better, working closely with these creative, high-impact organizations to accelerate progress toward the SDGs,” said Haruhiko Hirate, Corporate Communications & Public Affairs Officer. “We know that long-term commitments matter, and currently have nine programs in operation, running between 3 and 10 years. Each program is carefully selected by employees in our 80 countries of operation. It means a lot to all of us that Takeda is contributing to the health of people in communities across the globe.”

As a pharmaceutical company that is committed to improving people’s lives, Takeda strives for Better Health and a Brighter Future for people worldwide through leading innovation in medicine. Its vision is of a world with accessible healthcare for all, where prevention measures are exponentially advanced and billions are freed of disease. Takeda is committed to achieving the SDGs together with the global community.

Takeda also supports public-private partnerships that aim to improve health worldwide, together with the Government of Japan, such as The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Heath Innovative Technology (GHIT) Fund, and Coalition for Epidemic Preparedness Innovations (CEPI).

* Sustainable Development Goals (SDGs): On September 25th 2015, as part of the 2030 Agenda for Sustainable Development, the United Nations adopted a set of 17 goals, comprising 169 targets, for sustainable development.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Rare Diseases, and Neuroscience. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit www.takeda.com

About SeriousFun Children’s Network

SeriousFun Children’s Network is a global community of 30 camps and programs serving children with serious illnesses and their families, always free of charge. The Network is the leader in the field of medical specialty camps, delivering more than one million life-changing experiences to children and families from more than 50 countries. Each member camp is an independent, not-for-profit organization dependent upon private funding to serve all children at no cost to their families. To learn more about SeriousFun, visit www.seriousfunnetwork.org.